<DOC>
	<DOCNO>NCT00145769</DOCNO>
	<brief_summary>This multi-centre randomise trial compare long course ( LC ) preoperative chemoradiation short course ( SC ) preoperative radiotherapy patient localise T3 rectal cancer .</brief_summary>
	<brief_title>A Randomised Trial Preoperative Radiotherapy Stage T3 Adenocarcinoma Rectum</brief_title>
	<detailed_description>Objective : - The objective , patient T3 clinically resectable carcinoma rectum , demonstrate local recurrence rate patient treat long course ( LC ) pre-operative radiotherapy continuous infusion 5-FU low patient treat short course ( SC ) pre-operative radiotherapy early surgery Eligibility Criteria : - The main eligibility criterion patient clinically resectable adenocarcinoma rectum , clinical stage T3 tumour whose low border within 12 cm anal verge , evidence distant metastasis . Endpoints : - Primary endpoint local recurrence . - Secondary endpoint overall survival , toxicity , abdminoperineal resection rate , quality life . Treatment arm : - SC arm : Radiotherapy ( RT ) 25 Gy 5 fr 1 week follow surgery within 1 week 6 cycle postoperative chemotherapy 5FU/Folinic acid . - LC arm : RT 50.4 Gy 28 fr 5Â½weeks 5FU 225 mg/m2/day throughout course RT , follow surgery 4-6 week completion RT . 4 cycle adjuvant 5FU/Folinic acid give .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>All following must apply : Pathologically document clinically resectable adenocarcinoma rectum . The patient must consider surgeon suitable curative resection . The patient must consider radiation oncologist contraindication preoperative radiotherapy . Clinical T3 stage tumour endorectal ultrasound MRI . When endorectal ultrasound perform satisfactorily due technical reason , stenosis proximity tumour , MRI available , infiltration perirectal fat CT scan also acceptable . Tumour low border within 12 cm anal verge rigid sigmoidoscopy . ECOG performance status 0 , 1 2 . Adequate bone marrow function neutrophil count least 1.5 x 109/L platelet count least 100 x 109/L . Adequate liver function bilirubin alanine aminotransferase ( ALT ) &lt; = 1.5 time upper limit normal . Adequate renal function serum creatinine &lt; = 1.5 time upper limit normal . Accessibility treatment followup . Written informed consent . None follow must apply : Evidence distant metastasis . Recurrent rectal cancer . Unstable cardiac disease clinically significant active infection . Other cancer last 5 year except treated nonmelanoma skin cancer carcinoma situ cervix . Pregnant lactating female female patient childbearing potential surgically sterilize without adequate contraceptive measure . Contraindication insertion suitable indwell venous catheter e.g . implantable central venous device ( infuseaport ) , Hickman catheter peripherally inserted central catheter . Prior pelvic abdominal radiotherapy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>rectal cancer</keyword>
	<keyword>radiotherapy</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>chemoradiation</keyword>
	<keyword>adjuvant therapy</keyword>
</DOC>